🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
1. Objectives and Hypothesis 1. Objectives: This study evaluates...
Status
Unknown
Location
Jichi Medical Univercity
Start Date
2010-10
Trial ID
NCT01198496
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetic characteristic...
Status
Completed
Location
Inje University Pusan Paik Hospital
Start Date
2011-01
Trial ID
NCT01340131
Treatments Being Tested
To demonstrate that a fixed-dose combination of telmisartan 40 mg plus amlo...
Status
Completed
Location
1235.13.037 Boehringer Ingelheim Investigational Site
Start Date
2007-10
Trial ID
NCT00558064
Treatments Being Tested
Evaluation of 24-hour antihypertensive effect of long-acting ARB-CCB tablet...
Status
Unknown
Location
Uchiyama Clinic
Start Date
2012-11
Trial ID
NCT01748253
The aim of present study is to evaluate the efficacy and safety of two dose...
Status
Completed
Location
Seoul national university Bundang Hospital
Start Date
2012-07
Trial ID
NCT01634295
Treatments Being Tested
The purpose of this study is to evaluate the Pharmacokinetic drug interacti...
Status
Completed
Location
Asan Medical Center
Start Date
2011-06
Trial ID
NCT01356017
Treatments Being Tested
The objective of the study is to compare PPAR activities (increase of adipo...
Status
Completed
Location
502.486.3302A Cabinet Médical
Start Date
2005-11-03
Trial ID
NCT00242814
Treatments Being Tested
This observational study is designed to evaluate the effects of Twynsta tab...
Status
Completed
Location
Boehringer Ingelheim Investigational Site 15
Start Date
2011-03
Trial ID
NCT01316419
Treatments Being Tested
The primary objective of this trial is to assess the efficacy and safety of...
Status
Completed
Location
1235.8.61003 Boehringer Ingelheim Investigational Site
Start Date
2008-03
Trial ID
NCT00624052
A non-randomized, two-arm, single-sequence, crossover, open label, multiple...
Status
Completed
Location
Multiple Locations
Start Date
2015-11
Trial ID
NCT02933658
Treatments Being Tested